TCLlnc1 levels demonstrated significant distinguished early-stage and advanced-stage GC patients from healthy individuals, with respective area under the curve (AUC) values of 0.71 and 0.97, respectively. This evidence concerns the gene FTH1P24 and gastric cancer.